Inflammatory bowel disease drastically affects the prognosis of patients treated for peritoneal metastases with combined cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: a multicenter study

Conclusion CCRS followed by HIPEC is less effective in IBD patients with resectable PM complicating CRC or SBA. More careful selection of those patients is needed. Teaser Synopsis: To assess the feasibility and benefit of complete cytoreductive surgery followed by hyperthermic intraperitoneal chemotherapy in peritoneal metastases of colorectal/small bowel origin affecting patients with Inflammatory Bowel Disease.
Source: European Journal of Surgical Oncology (EJSO) - Category: Surgery Source Type: research